Inventory Summary of InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc.'s latest annual inventory in 2024 was 1.24 Million USD , down -23.02% from previous year.
InMed Pharmaceuticals Inc.'s latest quarterly inventory in 2024 Q4 was 1.24 Million USD , up 4.22% from previous quarter.
InMed Pharmaceuticals Inc. reported annual inventory of 1.61 Million USD in 2023, down -35.11% from previous year.
InMed Pharmaceuticals Inc. reported annual inventory of 2.49 Million USD in 2022, up 100.26% from previous year.
InMed Pharmaceuticals Inc. reported quarterly inventory of 1.24 Million USD for 2024 Q4, up 4.22% from previous quarter.
InMed Pharmaceuticals Inc. reported quarterly inventory of 1.19 Million USD for 2024 Q3, up 60.3% from previous quarter.

Annual Inventory Chart of InMed Pharmaceuticals Inc. (2024 - 2001)

Historical Annual Inventory of InMed Pharmaceuticals Inc. (2024 - 2001)

Year	Inventory	Inventory Growth
2024	1.24 Million USD	-23.02%
2023	1.61 Million USD	-35.11%
2022	2.49 Million USD	100.26%
2021	-955.8 Million USD	-103941406.1%
2020	-919.56 CAD	38.54%
2019	-1496.28 CAD	-3651395982259.09%
2018	- CAD	-100.0%
2017	2.00 CAD	0.0%
2016	- CAD	-100.0%
2015	1.00 CAD	47.83%
2014	0.68 CAD	0.0%
2013	- CAD	-100.0%
2012	0.16 CAD	539499432075.0%
2011	- CAD	0.0%
2010	- CAD	0.0%
2009	- CAD	-100.0%
2008	0.21 CAD	-100.0%
2007	11 Thousand CAD	1037.99%
2006	966.61 CAD	-41.98%
2005	1666.07 CAD	-84.8%
2004	10.95 Thousand CAD	-90.08%
2003	110.42 Thousand CAD	5453.53%
2002	-2062.60 CAD	85.71%
2001	-14.43 Thousand CAD	0.0%

Year	Inventory	Inventory Growth
2024 Q2	744.83 Thousand USD	-34.27%
2024 Q4	1.24 Million USD	4.22%
2024 Q3	1.19 Million USD	60.3%
2024 Q1	1.13 Million USD	-29.9%
2023 Q2	1.61 Million USD	-9.28%
2023 Q4	1.61 Million USD	21.54%
2023 FY	1.61 Million USD	-35.11%
2023 Q3	1.32 Million USD	-17.58%
2023 Q1	1.77 Million USD	-28.6%
2022 Q3	1.42 Million USD	43.64%
2022 Q4	2.49 Million USD	75.37%
2022 FY	2.49 Million USD	100.26%
2022 Q1	- USD	0.0%
2022 Q2	988.82 Thousand USD	0.0%
2021 Q4	- USD	0.0%
2021 Q1	- CAD	0.0%
2021 Q3	- USD	0.0%
2021 FY	-955.8 Million USD	-103941406.1%
2021 Q2	- USD	0.0%
2020 Q1	- CAD	-100.0%
2020 Q4	- CAD	0.0%
2020 Q3	- CAD	-100.0%
2020 Q2	- CAD	0.0%
2020 FY	-919.56 CAD	38.54%
2019 FY	-1496.28 CAD	-3651395982259.09%
2019 Q2	- CAD	0.0%
2019 Q3	- CAD	0.0%
2019 Q4	- CAD	0.0%
2019 Q1	- CAD	0.0%
2018 Q2	- CAD	0.0%
2018 FY	- CAD	-100.0%
2018 Q4	- CAD	0.0%
2018 Q3	- CAD	0.0%
2018 Q1	- CAD	0.0%
2017 Q2	- CAD	0.0%
2017 Q1	- CAD	0.0%
2017 FY	- CAD	0.0%
2017 Q4	- CAD	0.0%
2017 Q3	- CAD	0.0%
2016 Q2	- CAD	0.0%
2016 Q4	- CAD	0.0%
2016 Q3	- CAD	0.0%
2016 FY	- CAD	-100.0%
2016 Q1	- CAD	0.0%
2015 Q4	- CAD	0.0%
2015 Q2	- CAD	0.0%
2015 FY	- CAD	47.83%
2015 Q1	- CAD	0.0%
2015 Q3	- CAD	0.0%
2014 Q3	- CAD	0.0%
2014 Q1	- CAD	0.0%
2014 FY	- CAD	0.0%
2014 Q4	- CAD	0.0%
2014 Q2	- CAD	0.0%
2013 Q4	- CAD	0.0%
2013 Q3	- CAD	0.0%
2013 Q2	- CAD	0.0%
2013 Q1	- CAD	0.0%
2013 FY	- CAD	-100.0%
2012 Q3	- CAD	0.0%
2012 Q1	- CAD	0.0%
2012 Q2	- CAD	0.0%
2012 FY	- CAD	539499432075.0%
2012 Q4	- CAD	0.0%
2011 Q1	- CAD	0.0%
2011 FY	- CAD	0.0%
2011 Q4	- CAD	0.0%
2011 Q3	- CAD	0.0%
2011 Q2	- CAD	0.0%
2010 Q2	- CAD	0.0%
2010 Q3	- CAD	0.0%
2010 Q4	- CAD	0.0%
2010 FY	- CAD	0.0%
2010 Q1	- CAD	0.0%
2009 Q4	- CAD	0.0%
2009 FY	- CAD	-100.0%
2009 Q3	- CAD	0.0%
2009 Q2	- CAD	0.0%
2009 Q1	- CAD	0.0%
2008 Q2	706.86 CAD	-93.88%
2008 Q3	680.07 CAD	-3.79%
2008 Q4	- CAD	-100.0%
2008 FY	- CAD	-100.0%
2008 Q1	11.54 Thousand CAD	4.95%
2007 Q2	21.44 Thousand CAD	8.86%
2007 Q1	19.7 Thousand CAD	1938.25%
2007 FY	11 Thousand CAD	1037.99%
2007 Q4	11 Thousand CAD	-1.41%
2007 Q3	11.15 Thousand CAD	-47.98%
2006 Q3	62.76 Thousand CAD	1.4%
2006 FY	966.61 CAD	-41.98%
2006 Q2	61.89 Thousand CAD	0.0%
2006 Q1	- CAD	-100.0%
2006 Q4	966.61 CAD	-98.46%
2005 Q2	185.36 Thousand CAD	355.0%
2005 Q3	269.55 Thousand CAD	45.42%
2005 Q4	1666.07 CAD	-99.38%
2005 FY	1666.07 CAD	-84.8%
2005 Q1	40.74 Thousand CAD	271.75%
2004 Q2	32.64 Thousand CAD	-60.11%
2004 Q4	10.95 Thousand CAD	-89.42%
2004 FY	10.95 Thousand CAD	-90.08%
2004 Q1	81.81 Thousand CAD	-25.9%
2004 Q3	103.6 Thousand CAD	217.4%
2003 FY	110.42 Thousand CAD	5453.53%
2003 Q4	110.42 Thousand CAD	0.0%
2003 Q2	- CAD	0.0%
2003 Q1	- CAD	100.0%
2003 Q3	- CAD	0.0%
2002 Q2	-4918.92 CAD	47.88%
2002 Q1	-9438.43 CAD	0.0%
2002 Q4	-2062.60 CAD	0.41%
2002 Q3	-2071.20 CAD	57.89%
2002 FY	-2062.60 CAD	85.71%
2001 FY	-14.43 Thousand CAD	0.0%

Peer Inventory Comparison of InMed Pharmaceuticals Inc.

Name	Inventory	Inventory Difference
AbCellera Biologics Inc.	1.1 Million USD	-12.405%
Alkermes plc	186.4 Million USD	99.332%
Agenus Inc.	1.00 USD	-124432300.0%
Alnylam Pharmaceuticals, Inc.	89.14 Million USD	98.604%
Aptorum Group Limited	- USD	-Infinity%
Ardelyx, Inc.	12.44 Million USD	90.004%
Arrowhead Pharmaceuticals, Inc.	- USD	-Infinity%
Bicycle Therapeutics plc	- USD	-Infinity%
BioXcel Therapeutics, Inc.	1.99 Million USD	37.503%
ChromaDex Corporation	14.52 Million USD	91.433%
Chimerix, Inc.	- USD	-Infinity%
Corbus Pharmaceuticals Holdings, Inc.	- USD	-Infinity%
Caribou Biosciences, Inc.	- USD	-Infinity%
CRISPR Therapeutics AG	- USD	-Infinity%
Precision BioSciences, Inc.	- USD	-Infinity%
Dyadic International, Inc.	1.00 USD	-124432300.0%
Eton Pharmaceuticals, Inc.	911 Thousand USD	-36.589%
Fortress Biotech, Inc.	10.2 Million USD	87.808%
Lantern Pharma Inc.	- USD	-Infinity%
HOOKIPA Pharma Inc.	- USD	-Infinity%
Inhibikase Therapeutics, Inc.	- USD	-Infinity%
Incyte Corporation	62.97 Million USD	98.024%
IO Biotech, Inc.	- USD	-Infinity%
Jaguar Health, Inc.	9.18 Million USD	86.459%
Novavax, Inc.	41.69 Million USD	97.016%
Janux Therapeutics, Inc.	-2.2 Million USD	156.56%
Opthea Limited	- USD	-Infinity%
Ligand Pharmaceuticals Incorporated	23.96 Million USD	94.809%
ContextLogic Inc.	- USD	-Infinity%
MiMedx Group, Inc.	21.02 Million USD	94.081%
Pyxis Oncology, Inc.	- USD	-Infinity%
TransCode Therapeutics, Inc.	- USD	-Infinity%
NextCure, Inc.	- USD	-Infinity%
Ocuphire Pharma, Inc.	- USD	-Infinity%
Oncternal Therapeutics, Inc.	1.00 USD	-124432300.0%
Outlook Therapeutics, Inc.	- USD	-Infinity%
Vaxcyte, Inc.	-6.15 Million USD	120.203%
PDS Biotechnology Corporation	- USD	-Infinity%
Madrigal Pharmaceuticals, Inc.	- USD	-Infinity%
Pharming Group N.V.	56.76 Million USD	97.808%
Pieris Pharmaceuticals, Inc.	4.08 Million USD	69.554%
Avidity Biosciences, Inc.	- USD	-Infinity%
Reviva Pharmaceuticals Holdings, Inc.	- USD	-Infinity%
Reviva Pharmaceuticals Holdings, Inc.	- USD	-Infinity%
Sangamo Therapeutics, Inc.	- USD	-Infinity%
Sol-Gel Technologies Ltd.	- USD	-Infinity%
Acelyrin, Inc.	8.85 Million USD	85.941%
Salarius Pharmaceuticals, Inc.	- USD	-Infinity%
SELLAS Life Sciences Group, Inc.	- USD	-Infinity%
Summit Therapeutics Inc.	2.44 Million USD	49.024%
Sensei Biotherapeutics, Inc.	- USD	-Infinity%
Senti Biosciences, Inc.	- USD	-Infinity%
Stoke Therapeutics, Inc.	- USD	-Infinity%
Syros Pharmaceuticals, Inc.	- USD	-Infinity%
Alaunos Therapeutics, Inc.	- USD	-Infinity%
Telomir Pharmaceuticals, Inc. Common Stock	303.28 Thousand USD	-310.287%
Entrada Therapeutics, Inc.	1.00 USD	-124432300.0%
VistaGen Therapeutics, Inc.	- USD	-Infinity%
Wave Life Sciences Ltd.	1.00 USD	-124432300.0%
Sorrento Therapeutics, Inc.	9.97 Million USD	87.527%
TRACON Pharmaceuticals, Inc.	- USD	-Infinity%
Barinthus Biotherapeutics plc	1.00 USD	-124432300.0%
Psyence Biomedical Ltd.	- USD	-Infinity%
Phathom Pharmaceuticals, Inc.	1.2 Million USD	-3.007%
Immix Biopharma, Inc.	- USD	-Infinity%
Keros Therapeutics, Inc.	14.05 Million USD	91.146%
MEI Pharma, Inc.	- USD	-Infinity%
Windtree Therapeutics, Inc.	- USD	-Infinity%
Xeris Biopharma Holdings, Inc.	38.83 Million USD	96.796%
Rigel Pharmaceuticals, Inc.	5.52 Million USD	77.466%
Fortress Biotech, Inc.	10.2 Million USD	87.808%
Precigen, Inc.	1.00 USD	-124432300.0%
Clearside Biomedical, Inc.	1.00 USD	-124432300.0%
AlloVir, Inc.	- USD	-Infinity%
C4 Therapeutics, Inc.	- USD	-Infinity%
Fate Therapeutics, Inc.	- USD	-Infinity%
ImmuCell Corporation	7.81 Million USD	84.071%
IDEAYA Biosciences, Inc.	532.61 Million USD	99.766%
Onconetix, Inc.	364.05 Thousand USD	-241.798%
PureTech Health plc	- USD	-Infinity%
VYNE Therapeutics Inc.	- USD	-Infinity%
Elevation Oncology, Inc.	- USD	-Infinity%
Kintara Therapeutics, Inc.	- USD	-Infinity%
Seer, Inc.	4.49 Million USD	72.293%
Verrica Pharmaceuticals Inc.	1.02 Million USD	-21.754%
Innoviva, Inc.	40.73 Million USD	96.945%
Aadi Bioscience, Inc.	6.42 Million USD	80.639%
ESSA Pharma Inc.	- USD	-Infinity%
GlycoMimetics, Inc.	- USD	-Infinity%
GT Biopharma, Inc.	- USD	-Infinity%
Inhibrx Biosciences, Inc.	- USD	-Infinity%
Akebia Therapeutics, Inc.	15.69 Million USD	92.07%
Catalyst Pharmaceuticals, Inc.	15.64 Million USD	92.046%
Longboard Pharmaceuticals, Inc.	- USD	-Infinity%
Orchestra BioMed Holdings, Inc.	146 Thousand USD	-752.277%
Alzamend Neuro, Inc.	- USD	-Infinity%
Rocket Pharmaceuticals, Inc.	- USD	-Infinity%
Aptose Biosciences Inc.	- USD	-Infinity%
ZyVersa Therapeutics, Inc.	- USD	-Infinity%
Soligenix, Inc.	1.00 USD	-124432300.0%
Century Therapeutics, Inc.	- USD	-Infinity%
Kura Oncology, Inc.	- USD	-Infinity%
TScan Therapeutics, Inc.	- USD	-Infinity%
Intensity Therapeutics, Inc.	- USD	-Infinity%
Ocean Biomedical, Inc.	- USD	-Infinity%
CytomX Therapeutics, Inc.	- USD	-Infinity%
Autolus Therapeutics plc	-24.54 Million USD	105.07%
Mineralys Therapeutics, Inc.	- USD	-Infinity%
EyePoint Pharmaceuticals, Inc.	3.9 Million USD	68.143%
Eterna Therapeutics Inc.	- USD	-Infinity%
Adaptive Biotechnologies Corporation	14.44 Million USD	91.388%
GRI Bio, Inc.	- USD	-Infinity%
Xenetic Biosciences, Inc.	- USD	-Infinity%
Tenaya Therapeutics, Inc.	- USD	-Infinity%
IGM Biosciences, Inc.	- USD	-Infinity%
INmune Bio, Inc.	- USD	-Infinity%
Heron Therapeutics, Inc.	42.11 Million USD	97.045%
SAB Biotherapeutics, Inc.	- USD	-Infinity%
Pasithea Therapeutics Corp.	-40.5 Thousand USD	3172.405%
Entero Therapeutics, Inc.	- USD	-Infinity%
Milestone Pharmaceuticals Inc.	- USD	-Infinity%
X4 Pharmaceuticals, Inc.	- USD	-Infinity%
Atara Biotherapeutics, Inc.	9.7 Million USD	87.18%
Coherus BioSciences, Inc.	62.6 Million USD	98.012%
Verastem, Inc.	- USD	-Infinity%
Abeona Therapeutics Inc.	- USD	-Infinity%
Pliant Therapeutics, Inc.	- USD	-Infinity%
Tonix Pharmaceuticals Holding Corp.	14.14 Million USD	91.204%
Histogen Inc.	400 Thousand USD	-211.081%
Aprea Therapeutics, Inc.	- USD	-Infinity%
Surrozen, Inc.	1.00 USD	-124432300.0%
Organovo Holdings, Inc.	297 Thousand USD	-318.964%
Lixte Biotechnology Holdings, Inc.	- USD	-Infinity%
Ovid Therapeutics Inc.	- USD	-Infinity%
Panbela Therapeutics, Inc.	- USD	-Infinity%
CASI Pharmaceuticals, Inc.	15.87 Million USD	92.163%
Cadrenal Therapeutics, Inc. Common Stock	- USD	-Infinity%
Centessa Pharmaceuticals plc	1.00 USD	-124432300.0%
Hepion Pharmaceuticals, Inc.	- USD	-Infinity%
Arcturus Therapeutics Holdings Inc.	1.00 USD	-124432300.0%
BioRestorative Therapies, Inc.	1.00 USD	-124432300.0%
Apollomics, Inc.	-466 Thousand USD	367.022%
Amarin Corporation plc	258.61 Million USD	99.519%
Mesoblast Limited	- USD	-Infinity%
Turnstone Biologics Corp.	4.77 Million USD	73.919%
Kymera Therapeutics, Inc.	1.00 USD	-124432300.0%
Synaptogenix, Inc.	- USD	-Infinity%
Tiziana Life Sciences Ltd	- USD	-Infinity%
Aurinia Pharmaceuticals Inc.	39.7 Million USD	96.866%
BriaCell Therapeutics Corp.	-1.36 Million USD	190.892%
Monopar Therapeutics Inc.	- USD	-Infinity%
Exelixis, Inc.	17.32 Million USD	92.817%
Better Therapeutics, Inc.	- USD	-Infinity%
Nurix Therapeutics, Inc.	- USD	-Infinity%
Apellis Pharmaceuticals, Inc.	146.36 Million USD	99.15%
NLS Pharmaceutics AG	- USD	-Infinity%
Dermata Therapeutics, Inc.	- USD	-Infinity%
Aridis Pharmaceuticals, Inc.	- USD	-Infinity%
Gritstone bio, Inc.	- USD	-Infinity%
Jasper Therapeutics, Inc.	- USD	-Infinity%
TNF Pharmaceuticals, Inc.	- USD	-Infinity%
Avid Bioservices, Inc.	30.37 Million USD	95.903%
Insmed Incorporated	83.24 Million USD	98.505%
Virpax Pharmaceuticals, Inc.	- USD	-Infinity%
MediWound Ltd.	2.84 Million USD	56.278%
OmniAb, Inc.	1.00 USD	-124432300.0%
Alector, Inc.	- USD	-Infinity%
Seres Therapeutics, Inc.	29.64 Million USD	95.803%
Checkpoint Therapeutics, Inc.	- USD	-Infinity%
Viracta Therapeutics, Inc.	- USD	-Infinity%
Zai Lab Limited	44.82 Million USD	97.224%
Revance Therapeutics, Inc.	45.57 Million USD	97.27%
Aura Biosciences, Inc.	- USD	-Infinity%
Lyell Immunopharma, Inc.	- USD	-Infinity%
Immunic, Inc.	- USD	-Infinity%
Tarsus Pharmaceuticals, Inc.	3.1 Million USD	59.951%
Veracyte, Inc.	16.12 Million USD	92.285%
FibroGen, Inc.	41.56 Million USD	97.006%
SeaStar Medical Holding Corporation	- USD	-Infinity%
Adial Pharmaceuticals, Inc.	- USD	-Infinity%
Sonnet BioTherapeutics Holdings, Inc.	- USD	-Infinity%
Jazz Pharmaceuticals plc	597.03 Million USD	99.792%
Cyclacel Pharmaceuticals, Inc.	- USD	-Infinity%
Amylyx Pharmaceuticals, Inc.	38.32 Million USD	96.753%
TG Therapeutics, Inc.	39.82 Million USD	96.875%
Galecto, Inc.	1.00 USD	-124432300.0%
Calithera Biosciences, Inc.	- USD	-Infinity%
Fortrea Holdings Inc.	35.3 Million USD	96.475%
KalVista Pharmaceuticals, Inc.	- USD	-Infinity%
Aptevo Therapeutics Inc.	- USD	-Infinity%
XBiotech Inc.	- USD	-Infinity%
Jasper Therapeutics, Inc.	- USD	-Infinity%
Lyra Therapeutics, Inc.	- USD	-Infinity%
Foghorn Therapeutics Inc.	- USD	-Infinity%
Y-mAbs Therapeutics, Inc.	5.06 Million USD	75.433%
Theravance Biopharma, Inc.	1.00 USD	-124432300.0%
Ultragenyx Pharmaceutical Inc.	33.96 Million USD	96.337%
Metagenomi, Inc. Common Stock	- USD	-Infinity%
Vaxxinity, Inc.	- USD	-Infinity%
BioCryst Pharmaceuticals, Inc.	28.68 Million USD	95.662%
Gain Therapeutics, Inc.	- USD	-Infinity%
Cartesian Therapeutics, Inc.	- USD	-Infinity%
NexImmune, Inc.	- USD	-Infinity%
Creative Medical Technology Holdings, Inc.	6594.00 USD	-18770.549%
Marker Therapeutics, Inc.	1.00 USD	-124432300.0%
Regeneron Pharmaceuticals, Inc.	2.58 Billion USD	99.952%
Chemomab Therapeutics Ltd.	-1.03 Million USD	219.992%
Scopus BioPharma Inc.	- USD	-Infinity%
RAPT Therapeutics, Inc.	- USD	-Infinity%
Ainos, Inc.	167.59 Thousand USD	-642.468%
Pluri Inc.	222 Thousand USD	-460.506%
Prothena Corporation plc	-5.15 Million USD	124.119%
Adaptimmune Therapeutics plc	1.32 Million USD	6.371%
Celularity Inc.	5.75 Million USD	78.371%
Rallybio Corporation	- USD	-Infinity%
Cue Biopharma, Inc.	1.00 USD	-124432300.0%
MeiraGTx Holdings plc	- USD	-Infinity%
Omeros Corporation	8.58 Million USD	85.499%
Humacyte, Inc.	- USD	-Infinity%
Immunocore Holdings plc	4.5 Million USD	72.354%
Cocrystal Pharma, Inc.	- USD	-Infinity%
Cidara Therapeutics, Inc.	6.09 Million USD	79.591%
Blueprint Medicines Corporation	21.22 Million USD	94.137%
CalciMedica, Inc.	- USD	-Infinity%
Cabaletta Bio, Inc.	- USD	-Infinity%
Marinus Pharmaceuticals, Inc.	2.41 Million USD	48.432%
Scholar Rock Holding Corporation	- USD	-Infinity%
Sana Biotechnology, Inc.	- USD	-Infinity%
Pulmatrix, Inc.	- USD	-Infinity%
Elicio Therapeutics, Inc.	- USD	-Infinity%
Vigil Neuroscience, Inc.	- USD	-Infinity%
Intellia Therapeutics, Inc.	- USD	-Infinity%
Adlai Nortye Ltd. American Depositary Shares	1.00 USD	-124432300.0%
Cytokinetics, Incorporated	- USD	-Infinity%
Eloxx Pharmaceuticals, Inc.	- USD	-Infinity%
Nutriband Inc.	168.6 Thousand USD	-638.011%
Protara Therapeutics, Inc.	- USD	-Infinity%
Vor Biopharma Inc.	- USD	-Infinity%
Roivant Sciences Ltd.	35.25 Million USD	96.47%
Evogene Ltd.	1.69 Million USD	26.502%
ProKidney Corp.	- USD	-Infinity%
Applied Therapeutics, Inc.	- USD	-Infinity%
Hoth Therapeutics, Inc.	- USD	-Infinity%
BridgeBio Pharma, Inc.	16.65 Million USD	92.528%
CorMedix Inc.	2.1 Million USD	40.925%
BioLineRx Ltd.	1.95 Million USD	36.287%
Tango Therapeutics, Inc.	- USD	-Infinity%
Galectin Therapeutics Inc.	- USD	-Infinity%
Atai Life Sciences N.V.	1.00 USD	-124432300.0%
Renovaro Biosciences Inc.	-439.31 Thousand USD	383.24%
Aerovate Therapeutics, Inc.	- USD	-Infinity%
Zentalis Pharmaceuticals, Inc.	- USD	-Infinity%
Sagimet Biosciences Inc.	- USD	-Infinity%
MediciNova, Inc.	- USD	-Infinity%
Praxis Precision Medicines, Inc.	- USD	-Infinity%
Cardio Diagnostics Holdings, Inc.	- USD	-Infinity%
GeoVax Labs, Inc.	- USD	-Infinity%
Axsome Therapeutics, Inc.	15.13 Million USD	91.779%
Biomea Fusion, Inc.	- USD	-Infinity%
PTC Therapeutics, Inc.	30.57 Million USD	95.931%
Mereo BioPharma Group plc	1.24 Million USD	0.215%
Cullinan Oncology, Inc.	-5.4 Million USD	123.043%
Syndax Pharmaceuticals, Inc.	2 Million USD	37.877%
Absci Corporation	- USD	-Infinity%
NRx Pharmaceuticals, Inc.	-6000.00 USD	20838.733%
4D Molecular Therapeutics, Inc.	- USD	-Infinity%
Dyne Therapeutics, Inc.	- USD	-Infinity%
Kiniksa Pharmaceuticals, Ltd.	31.12 Million USD	96.002%
Ventyx Biosciences, Inc.	-800 Thousand USD	255.541%
Allakos Inc.	- USD	-Infinity%
Imunon, Inc.	- USD	-Infinity%
Fulcrum Therapeutics, Inc.	- USD	-Infinity%
Corcept Therapeutics Incorporated	7.73 Million USD	83.903%
BioAtla, Inc.	- USD	-Infinity%
NLS Pharmaceutics AG	- USD	-Infinity%
Bio-Path Holdings, Inc.	632.00 USD	-196786.709%
Allogene Therapeutics, Inc.	-1.7 Million USD	173.196%
Larimar Therapeutics, Inc.	- USD	-Infinity%
XOMA Corporation	1.00 USD	-124432300.0%
Kezar Life Sciences, Inc.	- USD	-Infinity%
Cara Therapeutics, Inc.	2.82 Million USD	55.891%
aTyr Pharma, Inc.	- USD	-Infinity%
Aligos Therapeutics, Inc.	- USD	-Infinity%
Akero Therapeutics, Inc.	- USD	-Infinity%
Viridian Therapeutics, Inc.	- USD	-Infinity%
Eliem Therapeutics, Inc.	- USD	-Infinity%
EyeGate Pharmaceuticals, Inc.	- USD	-Infinity%
Akari Therapeutics, Plc	- USD	-Infinity%
Tevogen Bio Holdings Inc.	- USD	-Infinity%
Halozyme Therapeutics, Inc.	127.6 Million USD	99.025%
Lexaria Bioscience Corp.	1.00 USD	-124432300.0%
UroGen Pharma Ltd.	5.67 Million USD	78.066%
Sutro Biopharma, Inc.	1.00 USD	-124432300.0%
ZIVO Bioscience, Inc.	- USD	-Infinity%
Orgenesis Inc.	34 Thousand USD	-3559.776%
Entera Bio Ltd.	- USD	-Infinity%
GH Research PLC	-178 Thousand USD	799.058%
Lisata Therapeutics, Inc.	- USD	-Infinity%
Reneo Pharmaceuticals, Inc.	- USD	-Infinity%
Xencor, Inc.	-11.29 Million USD	111.021%
60 Degrees Pharmaceuticals, Inc.	466.16 Thousand USD	-166.926%
Replimune Group, Inc.	- USD	-Infinity%
Coeptis Therapeutics Holdings, Inc.	- USD	-Infinity%
Vanda Pharmaceuticals Inc.	1.35 Million USD	8.303%
Lexaria Bioscience Corp.	1.00 USD	-124432300.0%
Portage Biotech Inc.	- USD	-Infinity%
Cardio Diagnostics Holdings, Inc.	- USD	-Infinity%
Olema Pharmaceuticals, Inc.	- USD	-Infinity%
OncoCyte Corporation	- USD	-Infinity%
Qualigen Therapeutics, Inc.	- USD	-Infinity%
Processa Pharmaceuticals, Inc.	- USD	-Infinity%
Purple Biotech Ltd.	- USD	-Infinity%
CollPlant Biotechnologies Ltd.	714 Thousand USD	-74.275%
scPharmaceuticals Inc.	8.84 Million USD	85.924%
ProMIS Neurosciences, Inc.	- USD	-Infinity%
HilleVax, Inc.	- USD	-Infinity%
NeuroSense Therapeutics Ltd.	- USD	-Infinity%
Tharimmune, Inc.	- USD	-Infinity%
Genprex, Inc.	- USD	-Infinity%
Neumora Therapeutics, Inc. Common Stock	- USD	-Infinity%
Atossa Therapeutics, Inc.	1.48 Million USD	16.32%
XTL Biopharmaceuticals Ltd.	- USD	-Infinity%
Virios Therapeutics, Inc.	- USD	-Infinity%
OKYO Pharma Limited	- USD	-Infinity%
Savara Inc.	1.00 USD	-124432300.0%
Curis, Inc.	- USD	-Infinity%
Daré Bioscience, Inc.	- USD	-Infinity%
Carmell Therapeutics Corporation	- USD	-Infinity%
Titan Pharmaceuticals, Inc.	- USD	-Infinity%
Achieve Life Sciences, Inc.	- USD	-Infinity%
BeiGene, Ltd.	416.12 Million USD	99.701%
Kiromic BioPharma, Inc.	- USD	-Infinity%
Revolution Medicines, Inc. Warrant	1.00 USD	-124432300.0%
Protagonist Therapeutics, Inc.	-10.33 Million USD	112.043%
Erasca, Inc.	- USD	-Infinity%
bluebird bio, Inc.	22.91 Million USD	94.571%
Protagenic Therapeutics, Inc.	- USD	-Infinity%
BioMarin Pharmaceutical Inc.	1.1 Billion USD	99.888%
DBV Technologies S.A.	- USD	-Infinity%
Protagenic Therapeutics, Inc.	- USD	-Infinity%
Moderna, Inc.	202 Million USD	99.384%
Vincerx Pharma, Inc.	- USD	-Infinity%
Fresh Tracks Therapeutics, Inc.	545 Thousand USD	-128.316%
Molecular Templates, Inc.	- USD	-Infinity%
Acrivon Therapeutics, Inc. Common Stock	- USD	-Infinity%
Travere Therapeutics, Inc.	9.41 Million USD	86.777%
Monte Rosa Therapeutics, Inc.	- USD	-Infinity%
Spruce Biosciences, Inc.	- USD	-Infinity%
Celldex Therapeutics, Inc.	1.00 USD	-124432300.0%
Cogent Biosciences, Inc.	- USD	-Infinity%
MacroGenics, Inc.	1.22 Million USD	-1.91%
RenovoRx, Inc.	- USD	-Infinity%
Adicet Bio, Inc.	- USD	-Infinity%
Prime Medicine, Inc.	- USD	-Infinity%
Aditxt, Inc.	745.5 Thousand USD	-66.911%
Adagene Inc.	- USD	-Infinity%
Estrella Immunopharma, Inc.	-288.76 Thousand USD	530.918%
Quantum-Si incorporated	3.94 Million USD	68.458%
Maravai LifeSciences Holdings, Inc.	51.39 Million USD	97.579%
Acurx Pharmaceuticals, Inc.	- USD	-Infinity%
Voyager Therapeutics, Inc.	1.00 USD	-124432300.0%
SciSparc Ltd.	742 Thousand USD	-67.699%
Vericel Corporation	13.08 Million USD	90.492%
Revelation Biosciences, Inc.	- USD	-Infinity%
Minerva Neurosciences, Inc.	- USD	-Infinity%
Generation Bio Co.	3.81 Million USD	67.392%
Astria Therapeutics, Inc.	- USD	-Infinity%
Black Diamond Therapeutics, Inc.	- USD	-Infinity%
Arcutis Biotherapeutics, Inc.	13.13 Million USD	90.526%
Invivyd, Inc.	- USD	-Infinity%
Relay Therapeutics, Inc.	- USD	-Infinity%
Quoin Pharmaceuticals, Ltd.	- USD	-Infinity%
Spero Therapeutics, Inc.	1.00 USD	-124432300.0%
Artelo Biosciences, Inc.	- USD	-Infinity%
2seventy bio, Inc.	-13.41 Million USD	109.278%
ADMA Biologics, Inc.	172.9 Million USD	99.28%
Clene Inc.	37 Thousand USD	-3263.038%
Capricor Therapeutics, Inc.	1.00 USD	-124432300.0%
Boundless Bio, Inc. Common Stock	- USD	-Infinity%
GeoVax Labs, Inc.	- USD	-Infinity%
Recursion Pharmaceuticals, Inc.	-3.09 Million USD	140.217%
Citius Pharmaceuticals, Inc.	- USD	-Infinity%
Contineum Therapeutics, Inc. Class A Common Stock	- USD	-Infinity%
Relmada Therapeutics, Inc.	- USD	-Infinity%
Finch Therapeutics Group, Inc.	- USD	-Infinity%
ALX Oncology Holdings Inc.	- USD	-Infinity%
Vir Biotechnology, Inc.	- USD	-Infinity%
Evaxion Biotech A/S	- USD	-Infinity%
Ocular Therapeutix, Inc.	2.3 Million USD	46.016%
Verve Therapeutics, Inc.	1.00 USD	-124432300.0%
Trevena, Inc.	- USD	-Infinity%
Surrozen, Inc.	1.00 USD	-124432300.0%
Tyra Biosciences, Inc.	- USD	-Infinity%
Cingulate Inc.	-14.62 Thousand USD	8609.944%
Galmed Pharmaceuticals Ltd.	- USD	-Infinity%
Unity Biotechnology, Inc.	- USD	-Infinity%
Tenax Therapeutics, Inc.	- USD	-Infinity%
Terns Pharmaceuticals, Inc.	- USD	-Infinity%
ACADIA Pharmaceuticals Inc.	35.81 Million USD	96.526%
Connect Biopharma Holdings Limited	-13.95 Million USD	108.919%
Clearmind Medicine Inc.	-11.39 Thousand USD	11020.775%
Kronos Bio, Inc.	- USD	-Infinity%
Bolt Biotherapeutics, Inc.	- USD	-Infinity%
CERo Therapeutics Holdings, Inc.	- USD	-Infinity%
Viking Therapeutics, Inc.	- USD	-Infinity%
Statera Biopharma, Inc.	1.8 Million USD	31.152%
ImmunityBio, Inc.	- USD	-Infinity%
Korro Bio, Inc.	- USD	-Infinity%
Kineta, Inc.	- USD	-Infinity%
BioVie Inc.	- USD	-Infinity%
Codexis, Inc.	2.68 Million USD	53.656%
Celularity Inc.	5.75 Million USD	78.371%
Crinetics Pharmaceuticals, Inc.	- USD	-Infinity%
Celcuity Inc.	- USD	-Infinity%
Virax Biolabs Group Limited	60.38 Thousand USD	-1960.719%
Cibus, Inc.	- USD	-Infinity%
Eledon Pharmaceuticals, Inc.	- USD	-Infinity%
eFFECTOR Therapeutics, Inc.	- USD	-Infinity%
IN8bio, Inc.	- USD	-Infinity%
Kodiak Sciences Inc.	- USD	-Infinity%
Annexon, Inc.	- USD	-Infinity%
Adverum Biotechnologies, Inc.	- USD	-Infinity%
Assembly Biosciences, Inc.	1.00 USD	-124432300.0%
Avalo Therapeutics, Inc.	- USD	-Infinity%
Ionis Pharmaceuticals, Inc.	28.42 Million USD	95.622%
Eyenovia, Inc.	109.79 Thousand USD	-1033.285%
Puma Biotechnology, Inc.	7.08 Million USD	82.425%
Conduit Pharmaceuticals Inc.	- USD	-Infinity%
Xilio Therapeutics, Inc.	- USD	-Infinity%
Arcellx, Inc.	- USD	-Infinity%
Cardiff Oncology, Inc.	- USD	-Infinity%
Enanta Pharmaceuticals, Inc.	- USD	-Infinity%
Regulus Therapeutics Inc.	3010.00 USD	-41239.668%
Moolec Science SA	465.74 Thousand USD	-167.167%
Acumen Pharmaceuticals, Inc.	98 Thousand USD	-1169.718%
Geron Corporation	- USD	-Infinity%
LAVA Therapeutics N.V.	- USD	-Infinity%
Royalty Pharma plc	- USD	-Infinity%
Atea Pharmaceuticals, Inc.	- USD	-Infinity%
Greenwich LifeSciences, Inc.	- USD	-Infinity%
TFF Pharmaceuticals, Inc.	- USD	-Infinity%
Mersana Therapeutics, Inc.	- USD	-Infinity%
Humacyte, Inc.	- USD	-Infinity%
Structure Therapeutics Inc.	- USD	-Infinity%
89bio, Inc.	- USD	-Infinity%
PMV Pharmaceuticals, Inc.	- USD	-Infinity%
Avenue Therapeutics, Inc.	- USD	-Infinity%
Genelux Corporation	- USD	-Infinity%
Trevi Therapeutics, Inc.	- USD	-Infinity%
Lexicon Pharmaceuticals, Inc.	381 Thousand USD	-226.594%
Notable Labs, Ltd.	2.88 Million USD	56.899%
Liquidia Corporation	1.00 USD	-124432300.0%
Mustang Bio, Inc.	- USD	-Infinity%
Immunovant, Inc.	- USD	-Infinity%
Quantum-Si incorporated	3.94 Million USD	68.458%
Arbutus Biopharma Corporation	-1.77 Million USD	170.063%
DiaMedica Therapeutics Inc.	- USD	-Infinity%
Vera Therapeutics, Inc.	- USD	-Infinity%
Acasti Pharma Inc.	- USD	-Infinity%
MiNK Therapeutics, Inc.	- USD	-Infinity%
Pasithea Therapeutics Corp.	-40.5 Thousand USD	3172.405%
Xenon Pharmaceuticals Inc.	1.00 USD	-124432300.0%
Elevai Labs, Inc. Common Stock	598.78 Thousand USD	-107.807%
NeuroBo Pharmaceuticals, Inc.	- USD	-Infinity%
Tempest Therapeutics, Inc.	- USD	-Infinity%
Soleno Therapeutics, Inc.	- USD	-Infinity%
PepGen Inc.	- USD	-Infinity%
Moleculin Biotech, Inc.	- USD	-Infinity%
United Therapeutics Corporation	111.8 Million USD	98.887%
Nuvectis Pharma, Inc.	- USD	-Infinity%
Solid Biosciences Inc.	- USD	-Infinity%
BriaCell Therapeutics Corp.	-1.36 Million USD	190.854%
Immuneering Corporation	- USD	-Infinity%
Lixte Biotechnology Holdings, Inc.	- USD	-Infinity%
Silo Pharma, Inc.	- USD	-Infinity%
Belite Bio, Inc	- USD	-Infinity%
XOMA Corporation	1.00 USD	-124432300.0%
ARS Pharmaceuticals, Inc.	- USD	-Infinity%
Bionomics Limited	-458.3 Million USD	100.272%
Apogee Therapeutics, Inc.	- USD	-Infinity%
Alpha Tau Medical Ltd.	- USD	-Infinity%
uniQure N.V.	12.02 Million USD	89.651%
Cassava Sciences, Inc.	- USD	-Infinity%
Estrella Immunopharma, Inc.	-288.76 Thousand USD	530.918%
Poseida Therapeutics, Inc.	1.00 USD	-124432300.0%
Forte Biosciences, Inc.	- USD	-Infinity%
Anebulo Pharmaceuticals, Inc.	- USD	-Infinity%
Enlivex Therapeutics Ltd.	-229 Thousand USD	643.373%
Conduit Pharmaceuticals Inc.	- USD	-Infinity%
SeaStar Medical Holding Corporation	- USD	-Infinity%
FibroBiologics, Inc. Common Stock	- USD	-Infinity%
Altimmune, Inc.	- USD	-Infinity%
Amicus Therapeutics, Inc.	59.69 Million USD	97.916%
Alpha Tau Medical Ltd.	- USD	-Infinity%
Compugen Ltd.	- USD	-Infinity%
Peak Bio, Inc.	1.91 Million USD	35.095%
Zevra Therapeutics, Inc.	9.84 Million USD	87.356%
Benitec Biopharma Inc.	63 Thousand USD	-1875.117%
Spyre Therapeutics, Inc.	- USD	-Infinity%
NKGen Biotech, Inc. Common Stock	- USD	-Infinity%
Zura Bio Limited	- USD	-Infinity%
PolyPid Ltd.	- USD	-Infinity%
Aileron Therapeutics, Inc.	- USD	-Infinity%
NKGen Biotech, Inc. Warrants	- USD	-Infinity%
Instil Bio, Inc.	- USD	-Infinity%
argenx SE	310.55 Million USD	99.599%
Immunome, Inc.	- USD	-Infinity%
Compass Therapeutics, Inc.	- USD	-Infinity%
Verona Pharma plc	1.00 USD	-124432300.0%
enGene Holdings Inc. Warrants	76 Thousand USD	-1537.268%
Shattuck Labs, Inc.	- USD	-Infinity%
CervoMed Inc.	- USD	-Infinity%
LENZ Therapeutics, Inc.	- USD	-Infinity%
Plus Therapeutics, Inc.	- USD	-Infinity%
Dianthus Therapeutics, Inc.	- USD	-Infinity%
Moolec Science SA	465.74 Thousand USD	-167.167%
Enveric Biosciences, Inc.	- USD	-Infinity%
Inovio Pharmaceuticals, Inc.	- USD	-Infinity%
AnaptysBio, Inc.	1.00 USD	-124432300.0%
Design Therapeutics, Inc.	- USD	-Infinity%
Leap Therapeutics, Inc.	- USD	-Infinity%
NeurAxis, Inc.	21.22 Thousand USD	-5763.921%
Seelos Therapeutics, Inc.	1.00 USD	-124432300.0%
Lumos Pharma, Inc.	- USD	-Infinity%
Achilles Therapeutics plc	1.00 USD	-124432300.0%
enGene Holdings Inc. Common Stock	76 Thousand USD	-1537.268%
180 Life Sciences Corp.	- USD	-Infinity%
Opiant Pharmaceuticals, Inc.	-2.95 Billion USD	100.042%
CERo Therapeutics Holdings, Inc.	- USD	-Infinity%
Nutriband Inc.	168.6 Thousand USD	-638.011%
ORIC Pharmaceuticals, Inc.	- USD	-Infinity%
CG Oncology, Inc. Common stock	- USD	-Infinity%
Fractyl Health, Inc. Common Stock	73 Thousand USD	-1604.553%
Rani Therapeutics Holdings, Inc.	- USD	-Infinity%
MoonLake Immunotherapeutics	- USD	-Infinity%
Palisade Bio, Inc.	- USD	-Infinity%
Tourmaline Bio, Inc.	- USD	-Infinity%
Beam Therapeutics Inc.	- USD	-Infinity%
Neurogene Inc.	1.49 Million USD	16.823%
Mirum Pharmaceuticals, Inc.	22.31 Million USD	94.423%
AEON Biopharma, Inc.	- USD	-Infinity%
CARGO Therapeutics, Inc. Common Stock	- USD	-Infinity%
Sesen Bio, Inc.	21 Million USD	94.075%
Enliven Therapeutics, Inc.	- USD	-Infinity%
Kiora Pharmaceuticals, Inc.	1.00 USD	-124432300.0%
Iovance Biotherapeutics, Inc.	10.37 Million USD	88.003%
Taysha Gene Therapies, Inc.	- USD	-Infinity%
Athira Pharma, Inc.	- USD	-Infinity%
Vaccinex, Inc.	- USD	-Infinity%
HCW Biologics Inc.	- USD	-Infinity%
XOMA Corporation	1.00 USD	-124432300.0%
Nektar Therapeutics	16.1 Million USD	92.272%
Arvinas, Inc.	- USD	-Infinity%
Tevogen Bio Holdings Inc.	- USD	-Infinity%
Merus N.V.	1.00 USD	-124432300.0%
Omega Therapeutics, Inc.	- USD	-Infinity%
Quince Therapeutics, Inc.	- USD	-Infinity%
Rezolute, Inc.	- USD	-Infinity%
Clene Inc.	37 Thousand USD	-3263.038%
Indaptus Therapeutics, Inc.	- USD	-Infinity%
BeyondSpring Inc.	- USD	-Infinity%
Synlogic, Inc.	- USD	-Infinity%
Allarity Therapeutics, Inc.	- USD	-Infinity%
Phio Pharmaceuticals Corp.	- USD	-Infinity%
Peak Bio, Inc.	1.91 Million USD	35.095%
Werewolf Therapeutics, Inc.	- USD	-Infinity%
Krystal Biotech, Inc.	6.98 Million USD	82.186%
Karyopharm Therapeutics Inc.	3.04 Million USD	59.109%
SpringWorks Therapeutics, Inc.	3.1 Million USD	59.899%
Lipella Pharmaceuticals Inc.	- USD	-Infinity%
MannKind Corporation	28.54 Million USD	95.641%
Ikena Oncology, Inc.	- USD	-Infinity%
Cyclerion Therapeutics, Inc.	- USD	-Infinity%
Gyre Therapeutics, Inc.	4.28 Million USD	70.934%
Gossamer Bio, Inc.	- USD	-Infinity%
CohBar, Inc.	- USD	-Infinity%
Cognition Therapeutics, Inc.	- USD	-Infinity%
NRx Pharmaceuticals, Inc.	-6000.00 USD	20838.733%
Legend Biotech Corporation	19.43 Million USD	93.597%
Mural Oncology plc	150 Thousand USD	-729.549%
Biora Therapeutics, Inc.	- USD	-Infinity%
PaxMedica, Inc. Common Stock	- USD	-Infinity%
Disc Medicine, Inc.	- USD	-Infinity%
Champions Oncology, Inc.	1.00 USD	-124432300.0%
REGENXBIO Inc.	- USD	-Infinity%
Ensysce Biosciences, Inc.	-97.56 Thousand USD	1375.432%
Anavex Life Sciences Corp.	- USD	-Infinity%
Cellectar Biosciences, Inc.	- USD	-Infinity%
Edgewise Therapeutics, Inc.	- USD	-Infinity%
Vaxart, Inc.	1.00 USD	-124432300.0%
PharmaCyte Biotech, Inc.	- USD	-Infinity%
Aldeyra Therapeutics, Inc.	- USD	-Infinity%
Cellectis S.A.	- USD	-Infinity%
Longeveron Inc.	- USD	-Infinity%
Repare Therapeutics Inc.	2.00 USD	-62216100.0%
Sarepta Therapeutics, Inc.	322.85 Million USD	99.615%
Inozyme Pharma, Inc.	- USD	-Infinity%
Revolution Medicines, Inc.	1.00 USD	-124432300.0%
Nymox Pharmaceutical Corporation	28 Thousand USD	-4344.014%
Third Harmonic Bio, Inc.	- USD	-Infinity%
ArriVent BioPharma, Inc. Common Stock	- USD	-Infinity%
AN2 Therapeutics, Inc.	- USD	-Infinity%
Anixa Biosciences, Inc.	- USD	-Infinity%
Vertex Pharmaceuticals Incorporated	738.8 Million USD	99.832%
Denali Therapeutics Inc.	1.00 USD	-124432300.0%
Revelation Biosciences, Inc.	- USD	-Infinity%
Veru Inc.	6.69 Million USD	81.42%
Corvus Pharmaceuticals, Inc.	- USD	-Infinity%
Cingulate Inc.	-14.62 Thousand USD	8609.944%
Passage Bio, Inc.	- USD	-Infinity%
Context Therapeutics Inc.	- USD	-Infinity%
Exicure, Inc.	- USD	-Infinity%
Day One Biopharmaceuticals, Inc.	- USD	-Infinity%
Oramed Pharmaceuticals Inc.	- USD	-Infinity%
Scinai Immunotherapeutics Ltd.	-1.87 Million USD	166.381%
Rhythm Pharmaceuticals, Inc.	8.62 Million USD	85.571%
Nuvalent, Inc.	- USD	-Infinity%
ABVC BioPharma, Inc.	- USD	-Infinity%
Carisma Therapeutics, Inc.	- USD	-Infinity%
Unicycive Therapeutics, Inc.	- USD	-Infinity%
OmniAb, Inc.	1.00 USD	-124432300.0%
Anew Medical, Inc.	- USD	-Infinity%
Fennec Pharmaceuticals Inc.	2.14 Million USD	41.989%
Lipocine Inc.	- USD	-Infinity%
Lexeo Therapeutics, Inc. Common Stock	- USD	-Infinity%
Nautilus Biotechnology, Inc.	- USD	-Infinity%
SAB Biotherapeutics, Inc.	- USD	-Infinity%
G1 Therapeutics, Inc.	12.44 Million USD	89.999%
Bellerophon Therapeutics, Inc.	- USD	-Infinity%
Sage Therapeutics, Inc.	1.33 Million USD	6.582%
Ocugen, Inc.	- USD	-Infinity%
Mind Medicine (MindMed) Inc.	- USD	-Infinity%
Q32 Bio Inc.	- USD	-Infinity%
Brainstorm Cell Therapeutics Inc.	-51 Thousand USD	2539.851%
Alumis Inc. Common Stock	- USD	-Infinity%
Equillium, Inc.	- USD	-Infinity%
Kyverna Therapeutics, Inc.	- USD	-Infinity%
Coya Therapeutics, Inc.	- USD	-Infinity%
CNS Pharmaceuticals, Inc.	- USD	-Infinity%
Galera Therapeutics, Inc.	- USD	-Infinity%
Evelo Biosciences, Inc.	- USD	-Infinity%
Comera Life Sciences Holdings, Inc.	2.5 Million USD	50.411%
Dominari Holdings Inc.	1.00 USD	-124432300.0%
Edesa Biotech, Inc.	- USD	-Infinity%
vTv Therapeutics Inc.	- USD	-Infinity%
Bio-Techne Corporation	179.73 Million USD	99.308%
Agios Pharmaceuticals, Inc.	19.07 Million USD	93.477%
Harmony Biosciences Holdings, Inc.	5.36 Million USD	76.798%
Prelude Therapeutics Incorporated	- USD	-Infinity%
Candel Therapeutics, Inc.	- USD	-Infinity%
iTeos Therapeutics, Inc.	- USD	-Infinity%
Nkarta, Inc.	- USD	-Infinity%
BioCardia, Inc.	- USD	-Infinity%
Iterum Therapeutics plc	- USD	-Infinity%

Global Stocks Search

InMed Pharmaceuticals Inc. (INM)

Inventory Summary of InMed Pharmaceuticals Inc.

Annual Inventory Chart of InMed Pharmaceuticals Inc. (2024 - 2001)

Historical Annual Inventory of InMed Pharmaceuticals Inc. (2024 - 2001)

Peer Inventory Comparison of InMed Pharmaceuticals Inc.